Literature DB >> 25421416

[Low dose naltrexone in the treatment of dissociative symptoms].

W Pape1, W Wöller.   

Abstract

BACKGROUND: Following the hypothesis that blocking opioid receptors leads to a decline in opiate-modulated dissociative phenomena, experiences with naltrexone as medication for dissociative symptoms have been gained since 1999 (mainly in doses of 25-100 mg/day). PATIENTS AND METHODS: In this study patients with severe trauma-related and dissociative disorders were treated with naltrexone in doses of 2-6 mg/day (0.06 mg/kg body weight).
RESULTS: The low dose treatment with naltrexone proved to be effective whereby 11 out of 15 patients reported immediate positive effects and 7 described a lasting helpful effect. The majority of patients who felt positive effects reported a clearer perception of both their surroundings and their inner life. Assessment of reality and dealing with it improved as did the perception of their own body and affects as well as self-regulation. The treatment was very low in side effects.
CONCLUSION: Treatment with low-dose naltrexone may be a helpful element in the treatment of patients with complex posttraumatic stress disorder. However, it has to be realized that the decrease of dissociation may lead patients to a not yet resolvable challenge, in as much as dissociation had previously been a necessary mechanism of self-protection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25421416     DOI: 10.1007/s00115-014-4015-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  10 in total

1.  Effect of naloxone therapy on depersonalization: a pilot study.

Authors:  Y L Nuller; M G Morozova; O N Kushnir; N Hamper
Journal:  J Psychopharmacol       Date:  2001-06       Impact factor: 4.153

2.  Evaluation of naltrexone for dissociative symptoms in borderline personality disorder.

Authors:  Christian Schmahl; Nikolaus Kleindienst; Matthias Limberger; Petra Ludäscher; Jana Mauchnik; Peter Deibler; Sonja Brünen; Christoph Hiemke; Klaus Lieb; Sabine Herpertz; Markus Reicherzer; Mathias Berger; Martin Bohus
Journal:  Int Clin Psychopharmacol       Date:  2012-01       Impact factor: 1.659

Review 3.  Are there two qualitatively distinct forms of dissociation? A review and some clinical implications.

Authors:  Emily A Holmes; Richard J Brown; Warren Mansell; R Pasco Fearon; Elaine C M Hunter; Frank Frasquilho; David A Oakley
Journal:  Clin Psychol Rev       Date:  2005-01

4.  Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study.

Authors:  Gad Lubin; Abraham Weizman; Mordechai Shmushkevitz; Avi Valevski
Journal:  Hum Psychopharmacol       Date:  2002-06       Impact factor: 1.672

Review 5.  Borderline personality disorder: a dysregulation of the endogenous opioid system?

Authors:  Borwin Bandelow; Christian Schmahl; Peter Falkai; Dirk Wedekind
Journal:  Psychol Rev       Date:  2010-04       Impact factor: 8.934

6.  Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

Authors:  M J Bohus; G B Landwehrmeyer; C E Stiglmayr; M F Limberger; R Böhme; C G Schmahl
Journal:  J Clin Psychiatry       Date:  1999-09       Impact factor: 4.384

7.  An open trial of naltrexone in the treatment of depersonalization disorder.

Authors:  Daphne Simeon; Margaret Knutelska
Journal:  J Clin Psychopharmacol       Date:  2005-06       Impact factor: 3.153

8.  Naloxone-reversible analgesic response to combat-related stimuli in posttraumatic stress disorder. A pilot study.

Authors:  R K Pitman; B A van der Kolk; S P Orr; M S Greenberg
Journal:  Arch Gen Psychiatry       Date:  1990-06

9.  [Questionnaire on dissociative symptoms. German adaptation, reliability and validity of the American Dissociative Experience Scale (DES)].

Authors:  H J Freyberger; C Spitzer; R D Stieglitz; G Kuhn; N Magdeburg; E Bernstein-Carlson
Journal:  Psychother Psychosom Med Psychol       Date:  1998-06

10.  Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability.

Authors:  Abdalla Bowirrat; Thomas J H Chen; Kenneth Blum; Margaret Madigan; John A Bailey; Amanda Lih Chuan Chen; B William Downs; Eric R Braverman; Shahien Radi; Roger L Waite; Mallory Kerner; John Giordano; Siohban Morse; Marlene Oscar-Berman; Mark Gold
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.